 SEATTLE, Sept. 10, 2021 GLOBE NEWSWIRE -- Icosavax, Inc. NASDAQ: ICVX, a biopharmaceutical company leveraging its innovative virus-like particle VLP platform technology to develop vaccines against infectious diseases, today announced the appointment of Elizabeth Bekiroğlu to General Counsel. 